These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9092641)

  • 21. Effect of p53 protein redox states on binding to supercoiled and linear DNA.
    Fojta M; Kubicárová T; Vojtĕsek B; Palecek E
    J Biol Chem; 1999 Sep; 274(36):25749-55. PubMed ID: 10464313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recognition of DNA modified by antitumor cisplatin by "latent" and "active" protein p53.
    Fojta M; Pivonkova H; Brazdova M; Kovarova L; Palecek E; Pospisilova S; Vojtesek B; Kasparkova J; Brabec V
    Biochem Pharmacol; 2003 Apr; 65(8):1305-16. PubMed ID: 12694871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA-conformation is an important determinant of sequence-specific DNA binding by tumor suppressor p53.
    Kim E; Albrechtsen N; Deppert W
    Oncogene; 1997 Aug; 15(7):857-69. PubMed ID: 9266973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Interaction of p53 with p53 response element like binding sequence at upstream of hepatitis B virus enhancer I].
    Qu JH; Zhu MH; Lin J; Ni CR; Li FM; Zhu Z; Yu GZ
    Ai Zheng; 2004 May; 23(5):502-7. PubMed ID: 15142443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of p53 activity by IkappaBalpha: evidence suggesting a common phylogeny between NF-kappaB and p53 transcription factors.
    Dreyfus DH; Nagasawa M; Gelfand EW; Ghoda LY
    BMC Immunol; 2005 Jun; 6():12. PubMed ID: 15969767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphorylation of p53 at the casein kinase II site selectively regulates p53-dependent transcriptional repression but not transactivation.
    Hall SR; Campbell LE; Meek DW
    Nucleic Acids Res; 1996 Mar; 24(6):1119-26. PubMed ID: 8604347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Derivation of the consensus DNA-binding sequence for p63 reveals unique requirements that are distinct from p53.
    Ortt K; Sinha S
    FEBS Lett; 2006 Aug; 580(18):4544-50. PubMed ID: 16870177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methods for the study of redox-mediated changes in p53 structure and function.
    Mann K
    Methods Mol Biol; 2008; 476():117-38. PubMed ID: 19157013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53-mediated transcription induces resistance of DNA to UV inactivation.
    Huang J; Logsdon N; Schmieg FI; Simmons DT
    Oncogene; 1998 Jul; 17(4):401-11. PubMed ID: 9696032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene.
    Chen J; Lin J; Levine AJ
    Mol Med; 1995 Jan; 1(2):142-52. PubMed ID: 8529093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional interaction between p53 and the interferon-inducible nucleoprotein IFI 16.
    Johnstone RW; Wei W; Greenway A; Trapani JA
    Oncogene; 2000 Dec; 19(52):6033-42. PubMed ID: 11146555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mammalian two-hybrid system: a complementary approach to the yeast two-hybrid system.
    Luo Y; Batalao A; Zhou H; Zhu L
    Biotechniques; 1997 Feb; 22(2):350-2. PubMed ID: 9043710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The proliferation-associated early response gene p22/PRG1 is a novel p53 target gene.
    Schäfer H; Trauzold A; Sebens T; Deppert W; Fölsch UR; Schmidt WE
    Oncogene; 1998 May; 16(19):2479-87. PubMed ID: 9627114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wild-type but not mutant p53 activates the hepatocyte growth factor/scatter factor promoter.
    Metcalfe AM; Dixon RM; Radda GK
    Nucleic Acids Res; 1997 Mar; 25(5):983-6. PubMed ID: 9023107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human tumor-derived p53 proteins exhibit binding site selectivity and temperature sensitivity for transactivation in a yeast-based assay.
    Di Como CJ; Prives C
    Oncogene; 1998 May; 16(19):2527-39. PubMed ID: 9627118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. APE1/Ref-1 enhances DNA binding activity of mutant p53 in a redox-dependent manner.
    Cun Y; Dai N; Li M; Xiong C; Zhang Q; Sui J; Qian C; Wang D
    Oncol Rep; 2014 Feb; 31(2):901-9. PubMed ID: 24297337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional modulation of estrogen receptor by redox state with reference to thioredoxin as a mediator.
    Hayashi S; Hajiro-Nakanishi K; Makino Y; Eguchi H; Yodoi J; Tanaka H
    Nucleic Acids Res; 1997 Oct; 25(20):4035-40. PubMed ID: 9321654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional activation of the egr-1 (early growth response-1) gene by hydrogen peroxide.
    Nose K; Ohba M
    Biochem J; 1996 Jun; 316 ( Pt 2)(Pt 2):381-3. PubMed ID: 8687376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53 protein is activated during muscle differentiation and participates with MyoD in the transcription of muscle creatine kinase gene.
    Tamir Y; Bengal E
    Oncogene; 1998 Jul; 17(3):347-56. PubMed ID: 9690516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional activation of the human proliferating-cell nuclear antigen promoter by p53.
    Morris GF; Bischoff JR; Mathews MB
    Proc Natl Acad Sci U S A; 1996 Jan; 93(2):895-9. PubMed ID: 8570655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.